Give a patient a GLP-1 prescription and send them home, and there is a decent chance the drug outlives their commitment to it. Six-month retention runs at around 45 per cent, by the estimate of a company sitting on data from more than 600,000 GLP-1 patients.
Wrap the same drug in a coaching service and…
